IV Connector Virtual Tour

Use the scroll bar to take the tour.  Fluid displacement was conducted on PVC tubing representative of a 2 Fr. PICC Catheter.

InVision-Plus® with Neutral Advantage™ Technology (RyMed)

 

The InVision-Plus® with Neutral Advantage™ Technology exhibits unique zero fluid displacement as verified by Nelson Labs (Lab No. 301988).  Zero blood reflux during connection and disconnection inhibits thrombotic occlusion and biofilm potential, eases educational burden by eliminating clamping sequences and positive pressure flush techniques, and affords clinicians a Heparin-free "saline-only" option. Zero fluid displacement enhances practices and optimizes outcomes.  The septum surface of the InVision-Plus® is smooth and swabbable with a standard 3-5 rotation technique.  It is also 99.94% effectively blood-cleared with a single 1 mL 0.9% NS flush.  The InVision-Plus® demonstrated 100% effectiveness in a recent independent in vitro 4-Day Microbial Barrier Performance Study in which samples were swabbed, aspirated, flushed and inoculated at repeated intervals with a 105 CFU medium of four microorganisms.  The InVision-Plus® is a key intraluminal protection, catheter care and maintenance component and has contributed to an elimination of CRBSI at Sutter Roseville Medical Center for over 3 years and a significant reduction of biofilm potential.  (See also Clinical Updates section, MD Anderson 10-Fold CRBSI Reduction poster available on request.)  The performance of the InVision-Plus® is a function of the RyMed 10-Point Standard, a comprehensive set of engineering and design-based features by which all IV connectors should be evaluated.

InVision-Plus® with Neutral Advantage™ Technology (RyMed)

InVision-Plus® with Neutral Advantage™ Technology (RyMed)

Zero Fluid Displacement upon connection AND disconnection.

 

The InVision-Plus® with Neutral Advantage™ Technology exhibits unique zero fluid displacement as verified by Nelson Labs (Lab No. 301988).  Zero blood reflux during connection and disconnection inhibits thrombotic occlusion and biofilm potential, eases educational burden by eliminating clamping sequences and positive pressure flush techniques, and affords clinicians a Heparin-free "saline-only" option. Zero fluid displacement enhances practices and optimizes outcomes.  The septum surface of the InVision-Plus® is smooth and swabbable with a standard 3-5 rotation technique.  It is also 99.94% effectively blood-cleared with a single 1 mL 0.9% NS flush.  The InVision-Plus® demonstrated 100% effectiveness in a recent independent in vitro 4-Day Microbial Barrier Performance Study in which samples were swabbed, aspirated, flushed and inoculated at repeated intervals with a 105 CFU medium of four microorganisms.  The InVision-Plus® is a key intraluminal protection, catheter care and maintenance component and has contributed to an elimination of CRBSI at Sutter Roseville Medical Center for over 3 years and a significant reduction of biofilm potential.  (See also Clinical Updates section, MD Anderson 10-Fold CRBSI Reduction poster available on request.)  The performance of the InVision-Plus® is a function of the RyMed 10-Point Standard, a comprehensive set of engineering and design-based features by which all IV connectors should be evaluated.

/assets/files/videos/InVisionDemoFixed.flv
MicroCLAVE® Connector (ICU Medical, Inc.)

MicroCLAVE® Connector (ICU Medical, Inc.)

Negative fluid displacement upon disconnection.

/assets/files/videos/MicroClaveDemoFixed.flv
CLAVE® Connector (ICU Medical, Inc.)

CLAVE® Connector (ICU Medical, Inc.)

Negative fluid displacement upon disconnection.

/assets/files/videos/ClaveDemoFixed.flv
MaxPlus® & MaxPlus® Clear (Maximus Medical, Inc.)

MaxPlus® & MaxPlus® Clear (Maximus Medical, Inc.)

A PPMV with negative fluid displacement immediately upon connection.

According to the 2008 IDSA/SHEA Compendium of Strategies to Prevent CLABSI, positive-pressure mechanical valves (PPMV) should not be routinely used as a part of CRBSI prevention efforts unless a thorough assessment of their risks, benefits, and education has been conducted.

The MaxPlus® Clear exhibits negative fluid displacement immediately upon connection. The repetitive blood reflux upon connection is a by-product of the moving part in the fluid pathway, typically a diaphragm or plunger-like valve, which compresses during connection, alters the chamber's volume and creates a vacuum, i.e. blood reflux.  Positive pressure (displacement) mechanical valves (PPMV) are largely believed to "clear" the catheter of blood and/or medications upon disconnection. But the real issue is one of blood fibrin development as repetitive cycles of blood reflux upon connection will condition the intraluminal catheter surfaces over time and affect catheter patency. More importantly, however, the internal moving part within PPMV typically creates a tortuous fluid pathway that complicates effective flushing.  Because of their higher priming volumes, PPMV have also shown a greater potential for biofilm development. PPMV have also been cited in the 2008 IDSA/SHEA Compendium and the VA Patient Advisory.  (See also, Cincinnati Children's Poster on MaxPlus®, White, Rupp).

/assets/files/videos/MaxPlusDemoFixed.flv
Clearlink® & V-Link w/VitalShield (Baxter)

Clearlink® & V-Link w/VitalShield (Baxter)

Negative fluid displacement upon disconnection. Clamping sequence required. No saline-only option.

The Clearlink® exhibits negative fluid displacement upon disconnection. Repetitive blood reflux upon disconnection, regardless of how minimal, will condition the intraluminal catheter surfaces over time and potentially affect catheter patency. Clamping sequence elimination combined with saline-only flushing should only be used in accordance with zero fluid displacement devices. Otherwise, the potential for intraluminal thrombotic catheter occlusions may persist.  The Clearlink® has also been associated with temporal increases in CRBSI (Jarvis, Jarvis) and may provide a less-than-optimal microbial barrier (Menyhay-Maki).  Because of its significantly higher priming volume, the Clearlink® may also carry a higher potential for biofilm adhesion potential and complicated flushing.  (Guy Cook)

/assets/files/videos/ClearLinkDemoFixed.flv
SmartSite® (Carefusion)

SmartSite® (Carefusion)

Negative fluid displacement upon disconnection. Clamping sequence reguired. No saline-only option.

The SmartSite® exhibits negative fluid displacement upon disconnection. Repetitive blood reflux upon disconnection, regardless of how minimal, will condition the intraluminal catheter surfaces over time and potentially affect catheter patency. Clamping sequence elimination combined with saline-only flushing should only be used in accordance with zero fluid displacement devices. Otherwise, the potential for intraluminal thrombotic catheter occlusions may persist.  The SmartSite® has also been associated with temporal increases in CRBSI (Jarvis, Jarvis, Salgado), and this is likely due to a combination of less-than-optimal design features, including a visible pre-slit which may harbor bacteria and inhibit surface disinfection, a single microbial barrier, and deadspace within the fluid pathway which may promote biofilm development and complicate effective flushing.

/assets/files/videos/SmartSiteDemoFixed.flv
Q-Syte™ Luer Access Split Septum (BD)

Q-Syte™ Luer Access Split Septum (BD)

Negative fluid displacement upon disconnection. Clamping sequence required. No saline-only option.

The Q-Syte™ exhibits negative fluid displacement upon disconnection. Repetitive blood reflux upon disconnection, regardless of how minimal, will condition the intraluminal catheter surfaces over time and potentially affect catheter patency. Clamping sequence elimination combined with saline-only flushing should only be used in accordance with zero fluid displacement devices. Otherwise, the potential for intraluminal thrombotic catheter occlusions may persist.  The Q-Syte™ carries an open fluid path.  The Q-Syte™ may provide a less-than-optimal microbial barrier due to the visible pre-slit septum surface, which may can harbor bacteria and complicate surface disinfection.  Click here to request the MD Anderson 10-Fold CRBSI Reduction poster.

/assets/files/videos/QSyteDemoFixed.flv
Ultrasite® (B. Braun)

Ultrasite® (B. Braun)

A PPMV with negative fluid displacement immediately upon connection.

According to the 2008 IDSA/SHEA Compendium of Strategies to Prevent CLABSI, positive-pressure mechanical valves (PPMV) should not be routinely used as a part of CRBSI prevention efforts unless a thorough assessment of their risks, benefits, and education has been conducted.

The Ultrasite® exhibits negative fluid displacement immediately upon connection. The repetitive blood reflux upon connection is a by-product of the moving part in the fluid pathway, typically a diaphragm or plunger-like valve, which compresses during connection, alters the chamber's volume and creates a vacuum, i.e. blood reflux.  Positive pressure (displacement) mechanical valves (PPMV) are largely believed to "clear" the catheter of blood and/or medications upon disconnection. But the real issue is one of blood fibrin development as repetitive cycles of blood reflux upon connection will condition the intraluminal catheter surfaces over time and affect catheter patency. Because of the internal moving part, PPMV are typically plagued by tortuous fluid pathways that complicate effective flushing.  Because of their higher priming volumes, PPMV have also shown a greater potential for biofilm development. PPMV have also been cited in the 2008 IDSA/SHEA Compendium and the VA Patient Advisory.  (See also, Jarvis, JarvisCincinnati Children's Poster on MaxPlus®, White, Rupp).  The Ultrasite® also contains metal components, which may affect MRI compatibility.

/assets/files/videos/UltraSiteDemoFixed.flv
CLC2000® (ICU Medical, Inc.)

CLC2000® (ICU Medical, Inc.)

A PPMV with negative fluid displacement immediately upon connection.

According to the 2008 IDSA/SHEA Compendium of Strategies to Prevent CLABSI, positive-pressure mechanical valves (PPMV) should not be routinely used as a part of CRBSI prevention efforts unless a thorough assessment of their risks, benefits, and education has been conducted.

The CLC2000® exhibits negative fluid displacement immediately upon connection. The repetitive blood reflux upon connection is a by-product of the moving part in the fluid pathway, typically a diaphragm or plunger-like valve, which compresses during connection, alters the chamber's volume and creates a vacuum, i.e. blood reflux.  Positive pressure (displacement) mechanical valves (PPMV) are largely believed to "clear" the catheter of blood and/or medications upon disconnection. But the real issue is one of blood fibrin development as repetitive cycles of blood reflux upon connection will condition the intraluminal catheter surfaces over time and affect catheter patency. Because of the internal moving part, PPMV are typically plagued by tortuous fluid pathways that complicate effective flushing.  Because of their higher priming volumes, PPMV have also shown a greater potential for biofilm development. PPMV have also been cited in the 2008 IDSA/SHEA Compendium and the VA Patient Advisory.  (See also, Cincinnati Children's Poster on MaxPlus®, White, Rupp, Field).  The CLC2000® also contains metal components, which may affect MRI compatibility.

/assets/files/videos/CLC2000DemoFixed.flv
Client Log-in
Submit
Staff Log-in
Submit
Corporate Headquarters
RyMed Technologies, Inc.
137 Third Avenue North
Franklin, TN 37064
Phone: 615-790-8093
FAX: 615-790-8984
E-Mail: info@rymedtech.com